First Time Loading...

Formycon AG
XETRA:FYB

Watchlist Manager
Formycon AG Logo
Formycon AG
XETRA:FYB
Watchlist
Price: 43.25 EUR -3.57%
Updated: May 8, 2024

Intrinsic Value

Formycon AG engages in the manufacture of biosimilar drugs and formulations. [ Read More ]

The intrinsic value of one FYB stock under the Base Case scenario is 53.88 EUR. Compared to the current market price of 43.25 EUR, Formycon AG is Undervalued by 20%.

Key Points:
FYB Intrinsic Value
Base Case
53.88 EUR
Undervaluation 20%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Formycon AG

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling FYB stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Formycon AG

Provide an overview of the primary business activities
of Formycon AG.

What unique competitive advantages
does Formycon AG hold over its rivals?

What risks and challenges
does Formycon AG face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Formycon AG.

Provide P/S
for Formycon AG.

Provide P/E
for Formycon AG.

Provide P/OCF
for Formycon AG.

Provide P/FCFE
for Formycon AG.

Provide P/B
for Formycon AG.

Provide EV/S
for Formycon AG.

Provide EV/GP
for Formycon AG.

Provide EV/EBITDA
for Formycon AG.

Provide EV/EBIT
for Formycon AG.

Provide EV/OCF
for Formycon AG.

Provide EV/FCFF
for Formycon AG.

Provide EV/IC
for Formycon AG.

Show me price targets
for Formycon AG made by professional analysts.

What are the Revenue projections
for Formycon AG?

How accurate were the past Revenue estimates
for Formycon AG?

What are the Net Income projections
for Formycon AG?

How accurate were the past Net Income estimates
for Formycon AG?

What are the EPS projections
for Formycon AG?

How accurate were the past EPS estimates
for Formycon AG?

What are the EBIT projections
for Formycon AG?

How accurate were the past EBIT estimates
for Formycon AG?

Compare the revenue forecasts
for Formycon AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Formycon AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Formycon AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of Formycon AG compared to its peers.

Compare the P/E ratios
of Formycon AG against its peers.

Discuss the investment returns and shareholder value creation
comparing Formycon AG with its peers.

Analyze the financial leverage
of Formycon AG compared to its main competitors.

Show all profitability ratios
for Formycon AG.

Provide ROE
for Formycon AG.

Provide ROA
for Formycon AG.

Provide ROIC
for Formycon AG.

Provide ROCE
for Formycon AG.

Provide Gross Margin
for Formycon AG.

Provide Operating Margin
for Formycon AG.

Provide Net Margin
for Formycon AG.

Provide FCF Margin
for Formycon AG.

Show all solvency ratios
for Formycon AG.

Provide D/E Ratio
for Formycon AG.

Provide D/A Ratio
for Formycon AG.

Provide Interest Coverage Ratio
for Formycon AG.

Provide Altman Z-Score Ratio
for Formycon AG.

Provide Quick Ratio
for Formycon AG.

Provide Current Ratio
for Formycon AG.

Provide Cash Ratio
for Formycon AG.

What is the historical Revenue growth
over the last 5 years for Formycon AG?

What is the historical Net Income growth
over the last 5 years for Formycon AG?

What is the current Free Cash Flow
of Formycon AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for Formycon AG.

Financials

Balance Sheet Decomposition
Formycon AG

Current Assets 67.1m
Cash & Short-Term Investments 27m
Receivables 28.3m
Other Current Assets 11.8m
Non-Current Assets 823.2m
Long-Term Investments 258m
PP&E 12.3m
Intangibles 552.9m
Current Liabilities 69.3m
Accounts Payable 16.3m
Other Current Liabilities 53m
Non-Current Liabilities 318.3m
Long-Term Debt 7.8m
Other Non-Current Liabilities 310.5m
Efficiency

Earnings Waterfall
Formycon AG

Revenue
77.7m EUR
Cost of Revenue
-54.8m EUR
Gross Profit
22.9m EUR
Operating Expenses
-23.3m EUR
Operating Income
-369k EUR
Other Expenses
76.2m EUR
Net Income
75.8m EUR

Free Cash Flow Analysis
Formycon AG

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

FYB Profitability Score
Profitability Due Diligence

Formycon AG's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Net Income
Exceptional 1-Year Revenue Growth
ROE is Increasing
47/100
Profitability
Score

Formycon AG's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

FYB Solvency Score
Solvency Due Diligence

Formycon AG's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Low D/E
Negative Net Debt
Long-Term Solvency
Short-Term Solvency
64/100
Solvency
Score

Formycon AG's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

FYB Price Targets Summary
Formycon AG

Wall Street analysts forecast FYB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FYB is 98.99 EUR with a low forecast of 81.81 EUR and a high forecast of 136.5 EUR.

Lowest
Price Target
81.81 EUR
89% Upside
Average
Price Target
98.99 EUR
129% Upside
Highest
Price Target
136.5 EUR
216% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

FYB Price
Formycon AG

1M 1M
-5%
6M 6M
-30%
1Y 1Y
-38%
3Y 3Y
-30%
5Y 5Y
+23%
10Y 10Y
+513%
Annual Price Range
43.25
52w Low
38.2
52w High
79.1
Price Metrics
Average Annual Return 32.12%
Standard Deviation of Annual Returns 46.39%
Max Drawdown -59%
Shares Statistics
Market Capitalization 687.9m EUR
Shares Outstanding 17 656 900
Percentage of Shares Shorted
N/A

FYB Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Formycon AG Logo
Formycon AG

Country

Germany

Industry

Biotechnology

Market Cap

687.9m EUR

Dividend Yield

0%

Description

Formycon AG engages in the manufacture of biosimilar drugs and formulations. The company is headquartered in Martinsried, Bayern and currently employs 159 full-time employees. The company went IPO on 2010-12-20. Its business activities are focused on the development and marketing of biopharmaceuticals that are similar to existing drugs, for which the patent protection is expiring. The firm focuses on treatments in the area of ophthalmology, immunology and other chronic diseases, covering all steps of biosimilar development process, from early-stage analysis of the originator drug to the preclinical and clinical testing phases, as well as the preparation of dossiers for marketing approval. Its biosimilar product pipeline consists of four candidates in pre-clinical and clinical testing phases, including FYB201, a biosimilar candidate for Lucentis; FYB202, a biosimilar candidate for Stelara; FYB203, a biosimilar candidate for Eylea, and FYB205.

Contact

BAYERN
Martinsried
Fraunhoferstrasse 15
+4989864667100.0
https://www.formycon.com/

IPO

2010-12-20

Employees

159

Officers

CEO & Member of Executive Board
Dr. Stefan Glombitza
Co-Founder
Dr. Nicolas Combe Ph.D.
CFO & Member of Management Board
Mr. Enno Spillner
Chief Scientific Officer & Member of Executive Board
Dr. Andreas Seidl
Chief Business Officer & Member of Executive Board
Ms. Nicola Mikulcik
Senior Manager of Corporate Communications & Investor Relations
Sabrina Muller

See Also

Discover More
What is the Intrinsic Value of one FYB stock?

The intrinsic value of one FYB stock under the Base Case scenario is 53.88 EUR.

Is FYB stock undervalued or overvalued?

Compared to the current market price of 43.25 EUR, Formycon AG is Undervalued by 20%.